TrialClinical pharmacokinetics2017

Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.

Sathej M Gopalakrishnan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.